Active Genetics & Molecular Biology Infection & Immunity

Epidemiological and functional dissection of the co-evolution between Plasmodium falciparum parasites and sickle haemoglobin.

In plain English

AI plain-English summary

The sickle cell mutation protects millions of people from severe malaria, but some malaria parasites have evolved genetic workarounds to evade that protection. Researchers in Kenya and the UK have discovered specific parasite mutations—called Pfsa loci—that allow *Plasmodium falciparum* to overcome the protective effect of sickle haemoglobin, yet no one knows how these mutations actually work. This matters because malaria remains a major killer in sub-Saharan Africa, and the sickle mutation is the strongest known natural defence against it. Understanding how parasites escape that defence could reveal fundamental rules of host–pathogen co-evolution—how a genetic change in humans drives counter-adaptations in a deadly parasite. The project is fundamental science: it aims to uncover the biological mechanisms behind this parasite escape, using gene editing, multi-omics, and population genetics. If successful, it will explain a key piece of the malaria resistance puzzle. That deeper understanding could, in the longer term, inform strategies for vaccine design or drug development—but the immediate goal is to answer a basic question about how two species shape each other’s evolution.

View original technical description
The "sickle" mutation (HbS; rs334 A>T) in the beta-globin gene (HBB) is the strongest known cause of natural resistance to Plasmodium falciparum malaria. While many mechanisms have been proposed to explain this protection, a recent paradigm-shifting study suggests that these should now be revisited. Through a large case-control study of severe malaria, we discovered that parasites could escape the protective effect of HbS if they carried mutations at specific P. falciparum sickle-associated (Pfsa) genetic loci. Such mutations are common in many African parasite populations, presumably due to HbS-driven natural selection, but the mechanisms by which they allow parasites to evade the protective effects of HbS remain completely unknown. We will discover these functional mechanisms by bringing together an interdisciplinary team of experts from Kenya and the UK to use epidemiological, population-genetic, multi-omic, parasite gene-editing and parasite phenotyping approaches to answer this fundamental question about host-pathogen co-evolution and human malaria resistance. Simultaneously, we will contribute to the development of science in Africa through shared leadership, the training of students, joint working, and technology transfer.

View the original record at the funder ↗

Researchers

Abdirahman Abdi (EPMC Awardee)Alexandra Rowe (EPMC Awardee)Lynette Oyier (EPMC Awardee)Sophie Uyoga (EPMC Awardee)Thomas Williams (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Epistasis and the genetics of disease resistance
The health consequences of genetic variants that have been selected by malaria, with a particular focus on polymorphisms affecting the red blood cell
Defining molecular determinants of Plasmodium falciparum hematopoietic infection using single cell profiling and genetics
Incorporating complex genetic and antigenic variation into host-parasite association studies
Evolutionary history of the sickle cell trait among Central African hunter-gatherers and farmers

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.